Friday, May 20, 2011

Isis receives $5M milestone payment from GSK for initiating ISIS-TTRRx Phase 1 study

Posted by https://www.med-chemist.com at 11:59 AM
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)